Trailing Twelve Months Revenue Growth: Incyte Pharma (INCY)

Public company logo of incyte.com (INCY)

Incyte Corporation (INCY) profitability is based on the success of Jakafi and growth in the dermatology segment. Comparative year-over-year sales dynamics over a rolling period visualize this trend, where the latest value is recorded as 24.90. A monopoly in the treatment of rare hematological diseases makes the company an indispensable alternative. Meanwhile, the expansion of drug indications scales profits, effectively offsetting R&D costs.

Incyte Corporation (INCY): Revenue Growth YoY (Last 12 Months) from 02/11/2024 to 11/18/2026

Incyte Corporation - analytical breakdowns and key metrics (INCY)

- stock price and consensus target price:
- company stock exchange capitalization indicators:
Summary company analytics:Incyte Corp.
Brand item of Incyte Pharma

For Incyte Corporation (INCY), which is currently in a phase of stabilizing revenues from its core oncology drugs, this metric serves as an indicator of portfolio diversification efficiency. By analyzing the last twelve months (LTM) growth rate of commercial revenue, an investor assesses the increase in aggregate sales over a rolling twelve-month period, which helps neutralize quarterly volatility and determine whether new dermatological products are offsetting the stagnation of previous cycles.

Who Incyte Corporation competes with

HUTCHMED Ltd (HCM) - Trailing Twelve Months Revenue Growth|NUVB - Sales Growth YoY (Last Twelve Months)|Trailing Twelve Months Revenue Growth Day One|MNPR: Sales Growth YoY (TTM)|Revenue Growth Rate YoY (Last Twelve Months) Inhibrx Biosciences Inc INBX|Revenue Growth YoY (Last 12 Months) IMAB|Trailing Twelve Months Revenue Growth Fennec Pharmaceuticals FENC|Revenue Growth YoY (Last 12 Months) HRTX (Heron)|NVCT (Nuvectis Pharma) - Revenue Dynamics YoY (Last Twelve Months)|Coherus Biosciences - Revenue Growth YoY (Last 12 Months)|Revenue Change YoY (Last 12 Months) CRBP (Corbus Pharmaceuticals Holdings)|Cardiff Oncology - Sales Growth YoY (TTM)|Revenue Dynamics YoY (Last Twelve Months) BYSI (BeyondSpring Pharma)|BCAB: Sales Growth YoY (TTM)|Trailing Twelve Months Revenue Growth lixte.com (LIXT)|Sales Growth YoY (Last Twelve Months) citiuspharma.com|CLRB: Revenue Dynamics YoY (Last Twelve Months)|Sales Growth YoY (TTM) BLRX|Sales Growth YoY (TTM) Can-Fite (CANF)|Sales Growth YoY (Last Twelve Months) Aprea Therapeutics Inc. APRE|KZIA (kaziatherapeutics.com) - Trailing Twelve Months Sales Growth|SLXN: Revenue Growth YoY (Last 12 Months)|Trailing Twelve Months Revenue Growth NuCana|CMRX: Sales Growth YoY (TTM)|Revenue Growth YoY (Last 12 Months) Cyclacel Pharmaceuticals|GTHX (g1therapeutics.com) - Sales Growth YoY (TTM)|KRON: Revenue Dynamics YoY (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) Kintara (KTRA)|Revenue Growth YoY (Last 12 Months) Oncternal ONCT|Portage Biotech - Revenue Growth YoY (Last 12 Months)